Vignesh Packiam, MD, discusses optimizing BCG treatment in high-risk NMIBC, including patient selection for combination immunotherapy and treatment-related trade-offs.
|Videos|September 1, 2022
Background of UReTER Mentorship Program for underrepresented populations in urology
Author(s)Urology Times staff
Advertisement
In this video Micha Yin-Zheng Cheng, MD, MPH, MS, a resident in the University of California San Francisco (UCSF) Department of Urology discusses the background of the
The 2021 AUA Census found that 2.4% of Urologists identify as Black & 4.4% as Hispanic. The UReTER Mentorship Program was created by residents in the UCSF Department of Urology as a resource for BIPOC (Black, Indigenous, People of Color) and Latinx Urology applicants. According to the program mission, its goal is to “create an annual opportunity for Urology to improve its diversity through resident-led mentorship of applicants who are underrepresented in our field.
Advertisement
Related to this article
Suzanne B. Merrill, MD, discusses emerging perioperative approaches in MIBC and the potential for more personalized treatment selection based on disease characteristics.
Benjamin Garmezy, MD, discusses personalizing mHSPC treatment intensification based on disease burden, molecular biomarkers, and patient-specific factors.
William Huang, MD, discusses histotripsy for renal tumors, the #HOPE4KIDNEY trial, and the technology’s potential to preserve kidney function.
Alicia Morgans, MD, discusses ARACOG findings on cognitive outcomes with darolutamide vs enzalutamide and the influence of genetic dementia risk.
Elie Kaplan-Marans, MD, discusses geographic disparities in reproductive urology access and how workforce gaps may affect comprehensive infertility evaluations.
Aaron Berger, MD, discusses patient selection for ARPI treatment holidays, monitoring during interruptions, and the role of testosterone recovery in interpreting PSA kinetics.
Paras H. Shah, MD, recaps data on emerging agents in high-risk NMIBC from the 2026 AUA North Central Section Meeting.
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants De Novo authorization to Virtuoso Robotic System for bladder tumor resection
2
Survey: Service members and veterans with NMIBC report barriers to treatment access
3
BCG-naïve NMIBC: Optimizing initial treatment selection
4
Q&A: Ronald Anglade, MD, on genetic testing in male infertility
5